Publication information
About Microdose Margin
A publication for the details that a headline cannot settle.
Our focus
Microdose Margin examines public records around advertised tirzepatide microdosing programs. A provider description, price card, safety-report count and clinical trial each supports a different kind of statement. Our articles keep those differences visible.
The margin has a purpose
The document reader places supported statements beside unsupported inferences and unresolved details. Its fixed examples invite careful reading. They do not determine a diagnosis, clinical risk, appropriate prescription or individual financial obligation.
Our publishing relationship
The coverage is editorial source research, without claimed patient experience, provider testing, clinician sign-off or a finding of clinical superiority.